A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPAR alpha) gene is associated with lower body mass index in patientswith non-insulin-dependent diabetes mellitus
D. Evans et al., A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPAR alpha) gene is associated with lower body mass index in patientswith non-insulin-dependent diabetes mellitus, J MOL MED-J, 79(4), 2001, pp. 198-204
Citations number
11
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
This study examined the effect a polymorphism (L162V) in the gene for perox
isome proliferator activated receptor (PPAR) alpha in the development of no
ninsulin-dependent diabetes mellitus (type 2 DM), obesity and hyperlipidaem
ia. The frequency of the L162V polymorphism in the PPAR alpha gene was dete
rmined in 370 morbidly obese patients who underwent gastric banding surgery
, 154 patients attending a type 2 DM clinic, 188 patients attending a lipid
clinic and 199 healthy blood donors. The overall frequency of the V allele
of the L162V polymorphism was 0.06. There were no significant differences
in the allele frequency between patients with morbid obesity, hyperlipidaem
ia, type 2 DM and healthy controls, suggesting that it does not play a majo
r role in the development of these conditions. The polymorphism was associa
ted with a lower body mass index (BMI) in two independently recruited group
s of patients with type 2, DM, There was no effect of the polymorphism on s
ubjects without type 2 DM, Thus a polymorphism in PPAR alpha protects type
2 DM patients from the overweight which is frequently associated with their
condition.